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A 70-year-old woman was admitted to hospital due to recurring symptomatic sustained ventricular tachycardias (VTs). She was 
diagnosed with ischaemic cardiomyopathy with low ejection fraction (20%). She also had left bundle branch block and chronic heart 
failure in New York Heart Association class III. Blood electrolyte levels were normal. Coronary angiography showed a preserved 
effect of previous angioplasty. Clostridium difficile infection was identified. Increasing levels of C-reactive protein and procalcitonin 
were observed. Despite treatment with metoprolol (100 mg per day) and amiodarone (1200 mg per day), VTs kept recurring; they 
had morphology of right bundle branch block with right axis deviation and cycle length of 240 ms. Ablation was performed using 
an anatomical visualisation system (CARTO). Potential map of the left ventricle revealed a large scar region. During left ventricular 
mapping VTs of the same morphology were induced with programmed ventricular stimulation (PVS). Areas of low conduction 
were removed. After ablation of late potentials, PVS demonstrated non-induction of VT. No arrhythmias were observed directly 
after the ablation, but an iatrogenic third-degree atrioventricular block occurred. The patient required temporary stimulation with 
indications to implantation of a permanent cardiac resynchronisation therapy defibrillator (CRT-D). However, the implantation 
was contraindicated due to an active infection. Therefore, a temporary external implantable cardioverter-defibrillator (ICD) with 
dual-coil lead and a conventional ICD was implanted on the opposite side of the planned permanent implantation. The implanta-
tion parameters were: R wave — 14 mV, impedance — 537 Ω, threshold — 1.2 V/0.5 ms. Defibrillation threshold test was not 
performed due to the generally serious condition of the patient. Two detection zones were programmed. The therapy started with 
anti-tachycardia pacing (ATP) — three attempts of burst: 12 cycles of 88% in the VT zone (141 bpm), followed by cardioversions 
(CVs), sending shocks between the two lead coils. Ventricular fibrillation zone (214 bpm) therapy consisted only of CVs. The ICD 
can was placed on the chest wall and attached with adhesives. The patient was scheduled for further infection treatment. After 
nine days she had recurrent VTs which had similar morphology to those previously observed and were successfully treated by both 
ATPs and CVs from the temporary ICD (Fig. 1). Further hospitalisation was uneventful. After normalisation of the inflammatory 
parameters, a permanent CRT-D was implanted. At one and six months of follow-up the patient’s condition improved with no 
arrhythmias or return of atrioventricular conduction. Treatment of an arrhythmic storm starts with the elimination of a potentially 
reversible cause, which can be established in about 66% of patients [1]. In this case, no such identifiable cause was found. In 
such situations treatment with antiarrhythmic medications, sedatives, and invasive methods is required. The OPTIC study showed 
that prevention of VT recurrence in patients with ICDs is effective with a combination of amiodarone and b-blockers [2]. In our 
patient, amiodarone with metoprolol did not prevent VT recurrence. The next step in the treatment is ablation, which not only 
stops electrical storm, but also improves long-term prognosis [3]. In our case VT returned shortly after ablation, probably due 
to the healing process after the procedure and an active infection. The infection was a reason against immediate implantation 
of a permanent CRT-D. We decided to use a bridge therapy with an external ICD with classic dual-coil lead, not only to ensure 
stimulation, but also to shorten the time of necessary treat-
ment application in the case of VT recurrence. The dual-coil 
lead was implanted because the can was not placed under the 
skin, but externally. The defibrillation dipole was programmed 
from coil to coil in order to ensure appropriate defibrillation 
impedance and prevent skin burning during CV. It proved to 
be an effective treatment — both ATP and CV were success-
ful. Programming of the VT zone was performed, although it 
was not line with the guidelines because previous VTs caused 
immediate decompensation of the patient.
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Figure 1. Ventricular tachycardias treated by anti-tachycardia 
pacing (A) and cardioversions (B) by an external implantable 
cardioverter-defibrillator
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